XML 10 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenue $ 142 $ 15,699
Cost of sales (54) (2,800)
Gross profit 88 12,899
Research and development costs (20,813) (11,845)
General and administrative expenses (7,684) (6,635)
Operating loss (28,409) (5,581)
Foreign currency (loss)/gain, net (3,769) 351
Other income, net 969 667
Benefit from R&D credit 2,679 2,495
Loss before income tax expense (28,530) (2,068)
Income tax expense 0 (244)
Net Loss $ (28,530) $ (2,312)
Loss per share basic $ (0.2) $ (0.02)
Loss per share diluted $ (0.2) $ (0.02)
Weighted-average shares outstanding basic 141,678,734 131,881,115
Weighted-average shares outstanding diluted 141,678,734 131,881,115